Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment

Behavioural Pharmacology

Volumn 8, Issue 6-7, 1997, Pages 607-618

  Dziedzicka Wasylewska, M ^a   Willner, P ^b   Papp, M ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Antidepressant drugs; Chronic mild stress; Dopamine; In situ hybridization; mRNA; Rat

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; FLUOXETINE; IMIPRAMINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; RAT; STRESS; SUBSTANTIA NIGRA;

EID: 0030846893     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199711000-00017     Document Type: Article

References (68)

1. American Psychiatric Association (1994) DSM IV - Diagnostic and Statistical Manual of Psychiatric Disorders, 4th edn. APA, Washington DC.
2. Arnt J, Hytell J and Overo KF (1984) Prolonged treatment with the specific 5-HT uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions. Polish Journal of Pharmacy and Pharmacology, 36, 221-230.
3. Bassareo V and Di Chiara G (1997) Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. Journal of Neuroscience, in press.
4. Beckstead RM (1979) An autoradiographic examination of cortical and subcortical projections of the mediodorsal projection (prefrontal) cortex in the rat. Journal of Comparative Neurology, 184, 43-62.
5. Blaha CD and Phillips AG (1996) A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviours. Behavioural Pharmacology, 7, 675-708.
6. 2 dopamine receptor cDNA. Nature, 336, 783-787.
7. Cador M, Robbins TW, Everitt BJ, Simon H, Le Moal M and Stinus L (1991) Limbic-striatal interactions in reward-related processes: modulation by the dopaminergic system. In: The Mesolimbic Dopamine System: From Motivation to Action (Eds P Willner and J Scheel-Kruger), pp. 225-250. Wiley, Chichester.
8. Cassens G, Wolfe L and Zola M (1990) The neuropsychology of depressions. Journal of Neuropsychiatry, 2, 202-213.
9. Cheeta S, Broekkamp C and Willner P (1994) Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer. Psychopharmacology, 116, 523-528.
10. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y and Van Tol HHM (1991) Molecular biology of the dopamine receptors. European Journal of Pharmacology, 207, 277-286.
11. 3H]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system. European Journal of Pharmacology, 167, 299-303.
12. Di Chiara G and Tanda L (1997) Blunting of reactivity of DA transmission to palatable food: a biochemical marker of anhedonia in the CMS model. Psychopharmacology, in press.
13. Dunnett SB and Iversen SD (1982) Regulatory impairments following selective 6-OHDA lesions of the neostriatum. Brain Res, 248, 121-127.
14. 2 dopamine receptors in the rat brain. Journal of Neural Transmission, in press.
15. Forbes NF, Stewart CA, Matthews K and Reid IC (1996) Chronic mild stress and sucrose consumption: validity as a model of depression. Physiology and Behavior, 60, 1481-1484.
16. Groenewegen HJ, Berendse HW, Meredith GE, Haber SN, Voorn P, Wolters JG and Lohman AHM (1991) Functional anatomy of the ventral, limbic system-innervated, striatum. In: The Mesolimbic Dopamine System: From Motivation to Action (Eds P Willner. and J Scheel-Kruger), pp. 19-59. Wiley, Chichester.
17. Jongen-Relo AL, Docter GJ, Jonker AJ, Vreugdenhil E, Groenewegen HJ and Voorn P (1994) Differential effects of dopamine depletion on the binding and mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens. Molecular Brain Research, 25, 333-343.
18. Klimek V and Maj J (1989) Repeated administration of antidepressant drugs enhanced agonist affinity for mesolimbic D-2 receptors. Journal of Pharmacy and Pharmacology, 41, 555-558.
19. Klimek V and Nielsen M (1987) Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system. European Journal of Pharmacology, 139, 163-169.
20. Le Moal M and Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory role. Physiological Reviews, 71, 155-234.
21. Maj J (1988) Repeated treatment with antidepressant drugs and functional changes of catecholaminergic receptors at the behavioural level. In: Progress in Catecholamine Research: Part C, Clinical Aspects (Eds RH Belmaker, M Sandler and A Dahlstrom), pp. 255-261. Liss, New York.
22. Maj J and Wedzony K (1985) Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens. Journal of Pharmacy and Pharmacology, 37, 362-364.
23. Maj J and Wedzony K (1988) The influence of oxaprotaline enantiomers given repeatedly on the behavioural effects of D-amphetamine and dopamine injected into the nucleus accumbens. European Journal of Pharmacology, 145, 97-103.
24. Maj J, Rogoz Z, Skuza G and Sowinska H (1984a) Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine. Journal of Pharmacy and Pharmacology, 36, 127-130.
25. Maj J, Rogoz Z, Skuza G and Sowinska H (1984b) Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine. Journal of Neural Transmission, 60, 273-282.
26. Maj J, Wedzony K and Klimek V (1987) Desipramine given repeatedly enhances behavioural effects of dopamine and D-amphetamine injected into the nucleus accumbens. European Journal of Pharmacology, 140,179-185.
27. 2 agonists. Journal of Neural Transmission, 76, 29-38.
28. 2 receptors in the rat brain. European Journal of Pharmacology, 304, 49-54.
29. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. Journal of Neuroscience, 10, 2587-2600.
30. 1 receptor binding and mRNA in rat brain using receptor autoradiographic analysis and in situ hybridization techniques. Neuroscience, 45, 359-371.
31. Marshall JF, Van Orrdt K and Kozlowski MR (1983) Acetylcholinesterase associated with dopaminergic innervation of the neostriatum: histochemical observations of a heterogeneous distribution. Brain Research, 274, 283-289.
32. Martin-Iverson M, Leclere JF and Fibiger HC (1983) Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants. European Journal of Pharmacology, 94, 193-201.
33. Matthews K, Forbes N and Reid IC (1995) Sucrose consumption as a hedonic measure following chronic unpredictable mild stress. Physiology and Behavior, 57, 241-248.
34. 2 receptor gene in the brain. Biological Psychiatry, 30, 985-1007.
35. 2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology, 5, 231-242.
36. Mogenson GJ, Jones DL and Yim CY (1982) From motivation to action: functional interface between the limbic system and the motor system. Progress in Neurobiology, 14, 69-97.
37. Moreau J-L, Jenck F, Martin JR, Mortas P and Haefely WE (1992) Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats. European Neuropsychopharmacology, 2, 43-49.
38. Moreau J-L, Jenck F, Martin JR, Mortas P and Haefely WE (1993) Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry, 26, 30-33.
39. Muscat R, Towell A and Willner P (1988) Changes in dopamine auto-receptor sensitivity in an animal model of depression. Psychopharmacology, 94, 545-550.
40. Muscat R, Sampson D and Willner P (1990) Dopaminergic mechanism of imipramine action in an animal model of depression. Biological Psychiatry, 28, 223-230.
41. Muscat R, Papp M and Willner P (1992) Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology, 109, 433-438.
42. 1 receptors by chronic imipramine is species specific. Pharmacology Biochemistry and Behavior, 39, 769-771.
43. Papp M, Willner P and Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology, 104, 255-259.
44. Papp M, Lappas S, Muscat R and Willner P (1992) Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. Journal of Psychopharmacology, 6, 352-356.
45. Papp M, Muscat R and Willner P (1993a) Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology, 110, 152-158.
46. Papp M, Klimek V and Willner P (1993b) Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression. Psychopharmacology, 114, 309-314.
47. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology, 115, 441-446.
48. Rampello L, Nicoletti G and Raffaele R (1991) Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatrica Scandinavica, 84, 552-554.
49. Rea MA and Simon JR (1981) Regional distribution of cholinergic parameters within the rat striatum. Brain Research, 219, 317-326.
50. Roth RH, Wolf ME and Deutch AY (1987) Neurochemistry of midbrain dopamine systems. In: Psychopharmacology: The Third Generation of Progress (Ed. HY Meltzer), pp. 81-94. Raven, New York.
51. Sampson D, Muscat R and Willner P (1991) Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology, 104, 491-495.
52. Scheel-Kruger J and Willner P (1991) The mesolimbic dopamine system: principles of operation. In: The Mesolimbic Dopamine System: From Motivation to Action (Eds P Willner. and J Scheel-Kruger), pp. 559-597. Wiley, Chichester.
53. Serra G, Argiolas A, Fadda F, Melis MR and Gessa GL (1979) Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Science, 25, 415-424.
54. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Brain Research, 527, 234-243.
55. Stamford JA, Muscat R, O'Connor JJ, Patel JJ, Wieczorek WJ, Kruk ZL and Willner P (1991) Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacology, 105, 275-282.
56. Towell A, Willner P and Muscat R (1986) Behavioural evidence for autoreceptor subsensitivity in the mesolimbic dopamine system during withdrawal from antidepressant drugs. Psychopharmacology, 90, 64-71.
57. Van Praag HM, Korf J, Lakke JPWF and Schut T (1975) Dopamine detablism in depression, psychoses and Parkinson's disease: the problem of specificity of biological variable in behavior disorders. Psychological Medicine, 5, 138-146.
58. Willner P (1983) Dopamine and depression: a review of recent evidence. Brain Research Reviews, 6, 211-224.
59. Willner P (1985) Depression: A Psychobiological Synthesis. Wiley, New York.
60. Willner P (1997) Validity, reliability and utility of the chronic mild stress (CMS) model of depression: a ten-year review and evaluation. Psychopharmacology, in press
61. Willner P and Montgomery A (1981) Behavioural changes during withdrawal from the tricyclic antidepressant desmethylimipramine (DMI). I. Interactions with amphetamine. Psychopharmacology, 75, 54-59.
62. Willner P and Papp M (1997) Animal models to detect antidepressants: are new strategies necessary to detect new agents? In: Antidepressants: New Pharmacological Strategies (Ed. P Skolnick), pp. 213-234. Humana, Totowa, NJ.
63. Willner P, Towell A, Sampson D, Sophokleous S and Muscat R (1987) Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology, 93, 358-364.
64. Willner P, Klimek V, Golembiowska K and Muscat R (1991) Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology, 19, 79-84.
65. Willner P, Muscat R and Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neuroscience and Biobehavioral Reviews, 16, 525-534.
66. Willner P, Moreau J-M, Nielsen C, Papp M and Sluzewska A (1996) Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight. Physiology and Behavior, 60, 129-134.
67. Winer BJ (1971) Statistical Principles in Experimental Design. McGraw-Hill, London.
68. 1 dopamine receptors. Nature, 347, 76-80.